Kandavel Thennarasu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kandavel Thennarasu has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Vivek Benegal
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bengaluru, India
5 shared publications - T. S. Jaisoorya
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bengaluru, India
4 shared publications - AB Taly
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
3 shared publications - Madhu Nagappa
Department of Neurology National Institute of Mental Health and Neurosciences (NIMHANS) Bangalore India
3 shared publications - Pratima Murthy
Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru 560 029, Karnataka, India
3 shared publications - Sanjib Sinha
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
3 shared publications
Latest Publications
- 24 May 2025
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 100, 106548
MOGAD treatment outcomes and relapse characteristics: Real world experience from a Low-Middle income country
- 24 May 2025
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 100, 106548
MOGAD treatment outcomes and relapse characteristics: Real world experience from a Low-Middle income country
- 15 June 2022
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 74, 103190
Risk estimates of anxiety and depressive disorders among primary care patients with chronic medical illness – A Indian study
- 15 June 2022
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 74, 103190
Risk estimates of anxiety and depressive disorders among primary care patients with chronic medical illness – A Indian study
- 10 March 2021
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 58, 102626
Mental health issues among health care workers during the COVID-19 pandemic – A study from India
- 10 March 2021
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 58, 102626
Mental health issues among health care workers during the COVID-19 pandemic – A study from India
- 1 March 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 282, 58-68
A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder
- 1 March 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 282, 58-68
A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder
- Open Access
- 2 January 2020
- Published by Springer Nature in BMC Psychiatry
- Vol. 20 (1) , 1-14
Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA): A developmental cohort study protocol
Background: Low and middle-income countries like India with a large youth population experience a different environment from that of high-income countries. The Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA), based in India, aims to examine environmental influences on genomic variations, neurodevelopmental trajectories and vulnerability to psychopathology, with a focus on externalizing disorders.Methods: cVEDA is a longitudinal cohort study, with planned missingness design for yearly follow-up. Participants have been recruited from multi-site tertiary care mental health settings, local communities, schools and colleges. 10,000 individuals between 6 and 23 years of age, of all genders, representing five geographically, ethnically, and socio-culturally distinct regions in India, and exposures to variations in early life adversity (psychosocial, nutritional, toxic exposures, slum-habitats, socio-political conflicts, urban/rural living, mental illness in the family) have been assessed using age-appropriate instruments to capture socio-demographic information, temperament, environmental exposures, parenting, psychiatric morbidity, and neuropsychological functioning. Blood/saliva and urine samples have been collected for genetic, epigenetic and toxicological (heavy metals, volatile organic compounds) studies. Structural (T1, T2, DTI) and functional (resting state fMRI) MRI brain scans have been performed on approximately 15% of the individuals. All data and biological samples are maintained in a databank and biobank, respectively.Discussion: The cVEDA has established the largest neurodevelopmental database in India, comparable to global datasets, with detailed environmental characterization. This should permit identification of environmental and genetic vulnerabilities to psychopathology within a developmental framework. Neuroimaging and neuropsychological data from this study are already yielding insights on brain growth and maturation patterns.
- 2 January 2020
- Published by Springer Nature in BMC Psychiatry
- Vol. 20 (1) , 1-14
Open AccessConsortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA): A developmental cohort study protocol
Background: Low and middle-income countries like India with a large youth population experience a different environment from that of high-income countries. The Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA), based in India, aims to examine environmental influences on genomic variations, neurodevelopmental trajectories and vulnerability to psychopathology, with a focus on externalizing disorders.Methods: cVEDA is a longitudinal cohort study, with planned missingness design for yearly follow-up. Participants have been recruited from multi-site tertiary care mental health settings, local communities, schools and colleges. 10,000 individuals between 6 and 23 years of age, of all genders, representing five geographically, ethnically, and socio-culturally distinct regions in India, and exposures to variations in early life adversity (psychosocial, nutritional, toxic exposures, slum-habitats, socio-political conflicts, urban/rural living, mental illness in the family) have been assessed using age-appropriate instruments to capture socio-demographic information, temperament, environmental exposures, parenting, psychiatric morbidity, and neuropsychological functioning. Blood/saliva and urine samples have been collected for genetic, epigenetic and toxicological (heavy metals, volatile organic compounds) studies. Structural (T1, T2, DTI) and functional (resting state fMRI) MRI brain scans have been performed on approximately 15% of the individuals. All data and biological samples are maintained in a databank and biobank, respectively.Discussion: The cVEDA has established the largest neurodevelopmental database in India, comparable to global datasets, with detailed environmental characterization. This should permit identification of environmental and genetic vulnerabilities to psychopathology within a developmental framework. Neuroimaging and neuropsychological data from this study are already yielding insights on brain growth and maturation patterns.
- 1 February 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 65, 111-117
Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study
- 1 February 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 65, 111-117
Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study
- Open Access
- 18 April 2018
- Published by Springer Nature in BMC Psychiatry
- Vol. 18 (1) , 106
Discovery biology of neuropsychiatric syndromes (DBNS): a center for integrating clinical medicine and basic science
There is emerging evidence that there are shared genetic, environmental and developmental risk factors in psychiatry, that cut across traditional diagnostic boundaries. With this background, the Discovery biology of neuropsychiatric syndromes (DBNS) proposes to recruit patients from five different syndromes (schizophrenia, bipolar disorder, obsessive compulsive disorder, Alzheimer’s dementia and substance use disorders), identify those with multiple affected relatives, and invite these families to participate in this study. The families will be assessed: 1) To compare neuro-endophenotype measures between patients, first degree relatives (FDR) and healthy controls., 2) To identify cellular phenotypes which differentiate the groups., 3) To examine the longitudinal course of neuro-endophenotype measures., 4) To identify measures which correlate with outcome, and 5) To create a unified digital database and biorepository. The identification of the index participants will occur at well-established specialty clinics. The selected individuals will have a strong family history (with at least another affected FDR) of mental illness. We will also recruit healthy controls without family history of such illness. All recruited individuals (N = 4500) will undergo brief clinical assessments and a blood sample will be drawn for isolation of DNA and peripheral blood mononuclear cells (PBMCs). From among this set, a subset of 1500 individuals (300 families and 300 controls) will be assessed on several additional assessments [detailed clinical assessments, endophenotype measures (neuroimaging- structural and functional, neuropsychology, psychophysics-electroencephalography, functional near infrared spectroscopy, eye movement tracking)], with the intention of conducting repeated measurements every alternate year. PBMCs from this set will be used to generate lymphoblastoid cell lines, and a subset of these would be converted to induced pluripotent stem cell lines and also undergo whole exome sequencing. We hope to identify unique and overlapping brain endophenotypes for major psychiatric syndromes. In a proportion of subjects, we expect these neuro-endophenotypes to progress over time and to predict treatment outcome. Similarly, cellular assays could differentiate cell lines derived from such groups. The repository of biomaterials as well as digital datasets of clinical parameters, will serve as a valuable resource for the broader scientific community who wish to address research questions in the area.
- 18 April 2018
- Published by Springer Nature in BMC Psychiatry
- Vol. 18 (1) , 106
Open AccessDiscovery biology of neuropsychiatric syndromes (DBNS): a center for integrating clinical medicine and basic science
There is emerging evidence that there are shared genetic, environmental and developmental risk factors in psychiatry, that cut across traditional diagnostic boundaries. With this background, the Discovery biology of neuropsychiatric syndromes (DBNS) proposes to recruit patients from five different syndromes (schizophrenia, bipolar disorder, obsessive compulsive disorder, Alzheimer’s dementia and substance use disorders), identify those with multiple affected relatives, and invite these families to participate in this study. The families will be assessed: 1) To compare neuro-endophenotype measures between patients, first degree relatives (FDR) and healthy controls., 2) To identify cellular phenotypes which differentiate the groups., 3) To examine the longitudinal course of neuro-endophenotype measures., 4) To identify measures which correlate with outcome, and 5) To create a unified digital database and biorepository. The identification of the index participants will occur at well-established specialty clinics. The selected individuals will have a strong family history (with at least another affected FDR) of mental illness. We will also recruit healthy controls without family history of such illness. All recruited individuals (N = 4500) will undergo brief clinical assessments and a blood sample will be drawn for isolation of DNA and peripheral blood mononuclear cells (PBMCs). From among this set, a subset of 1500 individuals (300 families and 300 controls) will be assessed on several additional assessments [detailed clinical assessments, endophenotype measures (neuroimaging- structural and functional, neuropsychology, psychophysics-electroencephalography, functional near infrared spectroscopy, eye movement tracking)], with the intention of conducting repeated measurements every alternate year. PBMCs from this set will be used to generate lymphoblastoid cell lines, and a subset of these would be converted to induced pluripotent stem cell lines and also undergo whole exome sequencing. We hope to identify unique and overlapping brain endophenotypes for major psychiatric syndromes. In a proportion of subjects, we expect these neuro-endophenotypes to progress over time and to predict treatment outcome. Similarly, cellular assays could differentiate cell lines derived from such groups. The repository of biomaterials as well as digital datasets of clinical parameters, will serve as a valuable resource for the broader scientific community who wish to address research questions in the area.
- 1 January 2018
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 31, 96-97
Problematic shopping behavior: Prevalence and implication for screening & intervention in health care setting
- 1 January 2018
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 31, 96-97
Problematic shopping behavior: Prevalence and implication for screening & intervention in health care setting
- 1 January 2018
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 31, 10-12
Toddlers at risk for Autism Spectrum Disorders from Kerala, India – A community based screening
- 1 January 2018
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 31, 10-12
Toddlers at risk for Autism Spectrum Disorders from Kerala, India – A community based screening
- 1 January 2018
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 31, 8-9
Gambling in an Indian community—An emerging mental health issue for exploration
- 1 January 2018
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 31, 8-9
Gambling in an Indian community—An emerging mental health issue for exploration